Innovent Biologics (信达生物) Placement - Back on the Market but This Time with Secondary Selldown
Innovent Biologics Inc (1801 HK) is looking to raise about U$290m to fund expansion and concurrently, shareholders are looking to sell about 33.8m...
483 Views
Legend Biotech IPO Initiation: Choosing Therapies À La CAR-T
Legend Biotech (BLG US) is one of the leading companies in developing CAR-T cell therapies in China, having received clearance for the first CAR-T...
150 Views
Short Interest Spiked for China Gas, Country Garden Svc, Big Covers for Innovent
Hong Kong SFC reported today for aggregate short position on Apr 29. The aggregate short value for equities increased by $1,489m (+2.7%) WoW and...
238 Views
Akesobio: Trading Debut, Valuation Scenario Analysis
Akeso Biopharma Inc (9926 HK) is a clinical-stage biopharmaceutical company with aims to address global unmet medical needs in oncology, immunology...
471 Views
Akesobio IPO: Valuation Insights
Akeso Biopharma Inc (9926 HK) is a clinical-stage biopharmaceutical company with aims to address global unmet medical needs in oncology, immunology...
475 Views